Terms: = Endocrine gland cancer AND CCND3, P30281, 896, ENSG00000112576 AND Treatment
20 results:
1. Risk-stratified Distant Metastatic Thyroid cancer with Clinicopathological Factors and BRAF/TERT Promoter Mutations.
Cheng X; Zhou Y; Xu S; Yu H; Wu J; Bao J; Zhang L
Exp Clin Endocrinol Diabetes; 2023 Nov; 131(11):577-582. PubMed ID: 37922948
[TBL] [Abstract] [Full Text] [Related]
2. Random Forest for Predicting treatment Response to Radioiodine and Thyrotropin Suppression Therapy in Patients With Differentiated Thyroid cancer But Without Structural Disease.
Sa R; Yang T; Zhang Z; Guan F
Oncologist; 2024 Jan; 29(1):e68-e80. PubMed ID: 37669005
[TBL] [Abstract] [Full Text] [Related]
3. Active surveillance is an excellent management technique for identifying patients with progressive low-risk papillary thyroid microcarcinoma requiring surgical treatment.
Fujishima M; Miyauchi A; Ito Y; Kudo T; Noda T; Sano T; Sasaki T; Kishi T; Nakamura T
Endocr J; 2023 Apr; 70(4):411-418. PubMed ID: 36631086
[TBL] [Abstract] [Full Text] [Related]
4. Who are the long-term survivors of recurrent ovarian carcinoma?: a retrospective analysis of a multicenter study.
Yoshihara M; Mogi K; Kitami K; Uno K; Iyoshi S; Tano S; Fujimoto H; Miyamoto E; Yoshikawa N; Emoto R; Matsui S; Kajiyama H
Int J Clin Oncol; 2022 Oct; 27(10):1660-1668. PubMed ID: 35906336
[TBL] [Abstract] [Full Text] [Related]
5. PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer.
Olsson Hau S; Wahlin S; Cervin S; Falk V; Nodin B; Elebro J; Eberhard J; Moran B; Gallagher WM; Karnevi E; Jirström K
J Pathol Clin Res; 2022 Jan; 8(1):65-77. PubMed ID: 34379360
[TBL] [Abstract] [Full Text] [Related]
6. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
[TBL] [Abstract] [Full Text] [Related]
7. Clinical efficacy of Stereotactic Body Radiation Therapy (SBRT) for adrenal gland metastases: A multi-center retrospective study from China.
Zhao X; Zhu X; Zhuang H; Guo X; Song Y; Ju X; Wang P; Yuan Z; Zhang H
Sci Rep; 2020 May; 10(1):7836. PubMed ID: 32398700
[TBL] [Abstract] [Full Text] [Related]
8. Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer.
Nipp R; Tramontano AC; Kong CY; Pandharipande P; Dowling EC; Schrag D; Hur C
Cancer Med; 2018 Feb; 7(2):525-535. PubMed ID: 29322643
[TBL] [Abstract] [Full Text] [Related]
9. Failure to Treat: Audit of an Institutional cancer Registry Database at a Large Comprehensive cancer Center Reveals Factors Affecting the treatment of Pancreatic cancer.
Miller-Ocuin JL; Zenati MS; Ocuin LM; Varley PR; Novak SM; Winters S; Zureikat AH; Zeh HJ; Hogg ME
Ann Surg Oncol; 2017 Aug; 24(8):2387-2396. PubMed ID: 28534079
[TBL] [Abstract] [Full Text] [Related]
10. Dopamine Agonists Can Reduce Cystic Prolactinomas.
Faje A; Chunharojrith P; Nency J; Biller BM; Swearingen B; Klibanski A
J Clin Endocrinol Metab; 2016 Oct; 101(10):3709-3715. PubMed ID: 27459530
[TBL] [Abstract] [Full Text] [Related]
11. Malnutrition Identified by the Nutritional Risk Index and Poor Prognosis in Advanced Epithelial Ovarian Carcinoma.
Yim GW; Eoh KJ; Kim SW; Nam EJ; Kim YT
Nutr Cancer; 2016 Jul; 68(5):772-9. PubMed ID: 27044606
[TBL] [Abstract] [Full Text] [Related]
12. National compliance to an evidence-based multidisciplinary guideline on pancreatic and periampullary carcinoma.
van Rijssen LB; van der Geest LG; Bollen TL; Bruno MJ; van der Gaast A; Veerbeek L; Ten Kate FJ; Busch OR
Pancreatology; 2016; 16(1):133-7. PubMed ID: 26560441
[TBL] [Abstract] [Full Text] [Related]
13. Time to recovery of adrenal function after curative surgery for Cushing's syndrome depends on etiology.
Berr CM; Di Dalmazi G; Osswald A; Ritzel K; Bidlingmaier M; Geyer LL; Treitl M; Hallfeldt K; Rachinger W; Reisch N; Blaser R; Schopohl J; Beuschlein F; Reincke M
J Clin Endocrinol Metab; 2015 Apr; 100(4):1300-8. PubMed ID: 25546155
[TBL] [Abstract] [Full Text] [Related]
14. Therapeutic options in locally advanced thyroid carcinoma. Our experience.
Avenia N; Monacelli M; Sanguinetti A; Santoprete S; Pecoriello R; Ragusa M; Puma F
Ann Ital Chir; 2012; 83(6):481-5. PubMed ID: 22615040
[TBL] [Abstract] [Full Text] [Related]
15. Judicious use of recombinant TSH in the management of differentiated thyroid carcinoma.
Khan MU; Nawaz MK; Shah MA; Syed AA; Khan AI
Ann Nucl Med; 2010 Oct; 24(8):609-15. PubMed ID: 20700666
[TBL] [Abstract] [Full Text] [Related]
16. Cost-effective management of low-risk papillary thyroid carcinoma.
Shrime MG; Goldstein DP; Seaberg RM; Sawka AM; Rotstein L; Freeman JL; Gullane PJ
Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1245-53. PubMed ID: 18086967
[TBL] [Abstract] [Full Text] [Related]
17. Clinical evaluation of human granulocyte colony-stimulating factor in chemotherapy for ovarian cancer.
Nagai N; Takehara K; Murakami T; Ohama K; Miyaoka S; Fujii T; Matsubayashi S
Hiroshima J Med Sci; 1995 Dec; 44(4):99-103. PubMed ID: 8857232
[TBL] [Abstract] [Full Text] [Related]
18. Parathyroid adenoma weight and the risk of death after treatment for primary hyperparathyroidism.
Hedbäck G; Odén A; Tisell LE
Surgery; 1995 Feb; 117(2):134-9. PubMed ID: 7846616
[TBL] [Abstract] [Full Text] [Related]
19. A phase II trial of intraperitoneal cisplatin and etoposide for primary treatment of ovarian epithelial cancer.
Howell SB; Kirmani S; Lucas WE; Zimm S; Goel R; Kim S; Horton MC; McVey L; Morris J; Weiss RJ
J Clin Oncol; 1990 Jan; 8(1):137-45. PubMed ID: 2295904
[TBL] [Abstract] [Full Text] [Related]
20. Pancreaticoduodenal resection. Surgical experience and evaluation of risk factors in 103 patients.
Lerut JP; Gianello PR; Otte JB; Kestens PJ
Ann Surg; 1984 Apr; 199(4):432-7. PubMed ID: 6712319
[TBL] [Abstract] [Full Text] [Related]
